Accounting
Accounting for Pharmaceutical Companies in the UAE
· 4 min read · By Aureus Worldwide
Pharmaceutical businesses in the UAE, importers, distributors and wholesalers of medicines, medical devices and healthcare products, operate in a regulated, dated and traceability-driven sector. Accounting here is inseparable from compliance: stock must be tracked by batch and expiry, many products are zero-rated for VAT while others are not, and returns and recalls are a recurring cost. A pharma distributor that mis-maps VAT rates across SKUs, or fails to provide for near-expiry stock, will misstate both tax and profit. This guide explains how to account for a UAE pharmaceutical business properly.
The pharma distribution model
A typical UAE pharma company imports registered products and distributes them to pharmacies, hospitals, clinics and other distributors. Margins vary widely by product and channel, and revenue is shaped by regulated pricing, tender business with large institutions, and the mix between high-volume generics and specialist products. The accounting must capture margin by product and by channel, because a blended figure hides where money is actually made.
Batch, expiry and cold-chain inventory
Inventory is the centre of pharma accounting and is tightly bound to regulation. Key disciplines:
- Track every item by batch number and expiry date
- Value stock at the lower of cost and net realisable value under IFRS
- Provide for near-expiry, slow-moving and damaged stock
- Account for cold-chain handling and the cost of compromised stock
- Maintain traceability so any batch can be located for recall
Dated stock that ages towards expiry must be written down before it is destroyed. Our inventory accounting guide covers valuation; the difference in pharma is that batch and expiry tracking is non-negotiable.
VAT: zero-rated medicines versus standard-rated goods
This is the area most specific to pharma. Certain pharmaceuticals and medical equipment listed under Cabinet Decision are zero-rated, while other health-related goods are standard-rated at 5%.
| Item | Typical VAT treatment |
|---|---|
| Listed medicines / medical equipment | Zero-rated (where on the approved list) |
| Non-listed health or consumer products | Standard-rated at 5% |
| Import of goods for resale | Often reverse charge; input tax usually recoverable |
| Export out of the UAE | May be zero-rated where conditions are met |
The practical task is mapping every SKU to the correct rate. Zero-rated does not mean exempt, input tax on related costs can usually still be recovered, but applying the wrong rate to a product line, in either direction, creates systematic VAT errors across high volumes. Confirm classifications with the FTA. Our VAT input tax recovery guide covers recovery on related costs.
Returns, recalls and provisions
Pharma carries a steady flow of returns and recalls, expired stock taken back from pharmacies, withdrawn batches, damaged goods. These must be provided for, not recognised only when they occur, so margin reflects reality. A returns and recall reserve, reviewed against actual experience, prevents the cost of withdrawn stock from distorting a single period.
A pharma chart of accounts
- Revenue: by product category and channel (retail, hospital, tender)
- Cost of sales: product cost, inbound freight, duty, cold-chain handling
- Inventory: by batch and expiry, with provisions for near-expiry and obsolescence
- Provisions: returns, recalls, slow-moving stock
- Operating expenses: warehousing, distribution, regulatory, sales
- Balance sheet: stock, institutional receivables, VAT control (mixed-rate)
The metrics that matter
- Gross margin by product and channel, not a blended figure
- Inventory days and expiry write-off rate, the cost of dated stock
- Near-expiry stock value, the provision waiting to happen
- Receivable days by channel, institutions often pay slowly
- Returns and recall rate, quality and leakage
In pharma, the balance sheet is a compliance record as much as a financial one. Distributors who do not track batch and expiry, and do not provide for near-expiry stock, find profit evaporating the day expired goods are destroyed.
Our KPIs guide explains how to turn these into a dashboard.
Cash flow and working capital
Pharma is working-capital intensive. Stock is imported and paid for up front, while hospitals and institutional buyers often pay on long terms. Tender business can mean large, lumpy receivables. Managing the cash conversion cycle, inventory days plus receivable days less payable days, is central, and a profitable distributor can still be cash-strained if institutional debtors are slow.
Corporate tax for pharma businesses
UAE corporate tax is charged at 9% on taxable profit above AED 375,000 and 0% below, based on accounting profit. Accurate batch-level inventory valuation, sensible near-expiry and recall provisions, and correct cost of sales all feed the computation. Over-valuing dated stock distorts taxable profit. Provide for the expected charge through the year and confirm specifics with the FTA or your adviser. See our corporate tax guide for the framework.
How Aureus Worldwide helps
Aureus Worldwide gives pharmaceutical businesses accounting that respects the regulation: batch- and expiry-level inventory, correct VAT mapping across zero-rated and standard-rated SKUs, and disciplined provisions for returns and recalls. Our accounting team keeps inventory and margins accurate, our tax service handles the mixed-rate VAT position and corporate tax, our CFO service turns product and channel margins into decisions, and our BPO and payroll service runs WPS payroll and bookkeeping for warehouse, regulatory and sales teams. To keep your pharma business compliant and profitable, contact us.
Frequently asked questions
Are medicines zero-rated for VAT in the UAE?
Certain pharmaceuticals and medical equipment listed under Cabinet Decision are zero-rated for UAE VAT, while other health-related goods may be standard-rated at 5%. Whether a specific product is zero-rated depends on whether it appears on the approved list, so each SKU should be mapped to its correct rate and the classification confirmed with the FTA.
Why is batch and expiry tracking essential in pharma accounting?
Pharmaceutical stock is dated and often temperature-sensitive, and regulators require traceability by batch. Accounting must track inventory by batch and expiry so stock can be valued at the lower of cost and net realisable value, near-expiry goods can be provided for, and recalls can be costed. Without batch-level records, both compliance and inventory valuation break down.
How are product returns and recalls accounted for in pharma?
Returns of expired or recalled stock are a normal feature of the sector and should be provided for, not just recognised when they occur. A returns and recall reserve, reviewed regularly against actual experience, keeps gross margin realistic and ensures the cost of withdrawn batches is matched to the right period.